Anthocyanins from a new hybrid sweet potato peel cultivated in Northern Thailand mitigate LPS-induced inflammation and RANKL-induced osteoporosis by regulating ROS-mediated pathways
Inflammopharmacology · 2025-01 · 33 (1) · 381-399
DOI: 10.1007/s10787-024-01634-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammopharmacology, online erschienen am 13.01.2025. Verfasst von Chalermpong Saenjum und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, 50200, Thailand. Hauptthemen laut MEDLINE: Anthocyanins, Ipomoea batatas, Inflammation, Reactive Oxygen Species. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of Higher Education, Science, Research and Innovation, Thailand.
Abstract (Originalsprache)
Maejo 341 Sweet potato (MSP) is a new purple sweet potato variety cultivated in Northern Thailand, but its health benefits are unknown. This study aimed to investigate its antioxidant, anti-inflammatory, and anti-osteoporotic activities, as well as its anthocyanin content. The peel and flesh of MSP were extracted with ethanol and water. Compared with the flesh extracts, the peel extracts presented greater antioxidant capacity and were rich in phenolics, flavonoids, and anthocyanins, namely, cyanidin-3-O-glucoside, peonidin-3-O-glucoside, pelargonidin-3-O-glucoside, cyanidin, and peonidin. The peel extracts suppressed lipopolysaccharide-induced inflammation by inhibiting the secretion of proinflammatory cytokines and enzymes, including TNF-α, IL-1β, IL-6, COX-2, and iNOS, as well as reducing nitric oxide and matrix metalloproteinase-9 secretion. The extracts inhibited the RANKL-induced NF-κB and MAPK pathways and downregulated osteoclastogenic marker expression. Under LPS and RANKL treatment, the peel extracts notably reduced reactive oxygen species production while increasing antioxidant gene expression. Furthermore, they increased osteoblast viability and slightly raise alkaline phosphatase activity. These findings suggest that MSP peel could be used as a functional food to alleviate oxidative stress and inflammation-related osteoporosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, 50200, Thailand.
- Research Center for Innovation in Analytical Science and Technology for Biodiversity-Based Economic and Society (I-ANALY-S-T_B. BES-CMU), Chiang Mai University, Chiang Mai, 50200, Thailand.
- Division of Biochemistry, School of Medical Sciences, University of Phayao, Phayao, 56000, Thailand.
- College of Pharmacy, Seoul National University, Seoul, 08826, South Korea.
- Division of Biochemistry, School of Medical Sciences, University of Phayao, Phayao, 56000, Thailand. kanokkarn.ph@up.ac.th.
Förderung
- Ministry of Higher Education, Science, Research and Innovation, Thailand
Zitieren
APA
Saenjum, C., Thim-Uam, A., Khonthun, C., Oonlao, P., Nuntaboon, P., Surh, Y. J., & Phromnoi, K. (2025). Anthocyanins from a new hybrid sweet potato peel cultivated in Northern Thailand mitigate LPS-induced inflammation and RANKL-induced osteoporosis by regulating ROS-mediated pathways. Inflammopharmacology, 33(1), 381-399. https://doi.org/10.1007/s10787-024-01634-5
Vancouver
Saenjum C, Thim-Uam A, Khonthun C, Oonlao P, Nuntaboon P, Surh YJ, et al. Anthocyanins from a new hybrid sweet potato peel cultivated in Northern Thailand mitigate LPS-induced inflammation and RANKL-induced osteoporosis by regulating ROS-mediated pathways. Inflammopharmacology. 2025;33(1):381-399. doi:10.1007/s10787-024-01634-5
BibTeX
@article{Saenjum2025,
author = {Saenjum, Chalermpong and Thim-Uam, Arthid and Khonthun, Chakkraphong and Oonlao, Panida and Nuntaboon, Piyawan and Surh, Young-Joon and Phromnoi, Kanokkarn},
title = {Anthocyanins from a new hybrid sweet potato peel cultivated in Northern Thailand mitigate LPS-induced inflammation and RANKL-induced osteoporosis by regulating ROS-mediated pathways},
journal = {Inflammopharmacology},
year = {2025},
volume = {33},
number = {1},
pages = {381--399},
doi = {10.1007/s10787-024-01634-5}
}
EUVIMED